Filip Adjic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Filip Adjic has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anja Ristic
University of East Sarajevo, Faculty of Medicine, Foča, Republic of Srpska, Bosnia and Herzegovina
1 shared publication - Mara Adjic
University of Novi Sad, Faculty of Medicine, Novi Sad + Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica
1 shared publication - Nikolina Konstantinovic
University of Novi Sad, Faculty of Medicine, Novi Sad
1 shared publication - Viktor Brusnjai
University of Novi Sad, Faculty of Medicine, Novi Sad
1 shared publication
Latest Publications
- 1 January 2026
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 79 (3-6) , 116-121
Predictors of recurrence of sudden cardiac arrest in patients treated with an implantable cardioverter defibrillator
Introduction. Randomised clinical trials have demonstrated the indispensable role of implantable cardioverter defibrillators in reducing mortality among patients at high risk of sudden cardiac death. This study aimed to assess the incidence and predictors of cardiac arrest recurrence in such patients. Material and Methods. This retrospective study included 240 patients who underwent defibrillator implantation for secondary prevention at the Institute for Cardiovascular Diseases of Vojvodina between 2008 and 2020. The cumulative incidence of recurrence was determined using Kaplan-Meier curves, while Cox regression was used to identify predictors of sudden cardiac arrest recurrence. Results. The median follow-up was 4.46 years, and recurrence of sudden cardiac arrest occurred in 60% (n=144) of patients. Sustained ventricular tachycardia as the indication for implantation was shown to be an independent predictor of recurrence. These patients also had a significantly higher number of hospitalisations during follow-up. Patients diagnosed with channelopathy or arrhythmogenic right ventricular dysplasia had a significantly higher number of hospitalisations than those diagnosed with ischaemic or non-ischaemic cardiomyopathy. Conclusion. The incidence of sudden cardiac arrest recurrence following defibrillator implantation is high across all patient groups, regardless of aetiology. Sustained ventricular tachycardia as the indication for device implantation predicts a higher incidence of cardiac arrest recurrence.
- 1 January 2026
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 79 (3-6) , 116-121
Predictors of recurrence of sudden cardiac arrest in patients treated with an implantable cardioverter defibrillator
Introduction. Randomised clinical trials have demonstrated the indispensable role of implantable cardioverter defibrillators in reducing mortality among patients at high risk of sudden cardiac death. This study aimed to assess the incidence and predictors of cardiac arrest recurrence in such patients. Material and Methods. This retrospective study included 240 patients who underwent defibrillator implantation for secondary prevention at the Institute for Cardiovascular Diseases of Vojvodina between 2008 and 2020. The cumulative incidence of recurrence was determined using Kaplan-Meier curves, while Cox regression was used to identify predictors of sudden cardiac arrest recurrence. Results. The median follow-up was 4.46 years, and recurrence of sudden cardiac arrest occurred in 60% (n=144) of patients. Sustained ventricular tachycardia as the indication for implantation was shown to be an independent predictor of recurrence. These patients also had a significantly higher number of hospitalisations during follow-up. Patients diagnosed with channelopathy or arrhythmogenic right ventricular dysplasia had a significantly higher number of hospitalisations than those diagnosed with ischaemic or non-ischaemic cardiomyopathy. Conclusion. The incidence of sudden cardiac arrest recurrence following defibrillator implantation is high across all patient groups, regardless of aetiology. Sustained ventricular tachycardia as the indication for device implantation predicts a higher incidence of cardiac arrest recurrence.